Tenet Healthcare Corp. Director John Ellis Bush Unloads 16,582 Shares (THC)
Tenet Healthcare Corp. (NYSE:THC) Director John Ellis Bush sold 16,582 shares of the stock in a transaction that occurred on Thursday, October 3rd. The stock was sold at an average price of $45.10, for a total transaction of $747,848.20. Following the sale, the director now directly owns 20,331 shares in the company, valued at approximately $916,928. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Tenet Healthcare Corp. (NYSE:THC) traded down 0.37% during mid-day trading on Friday, hitting $46.10. The stock had a trading volume of 2,488,000 shares. Tenet Healthcare Corp. has a one year low of $22.86 and a one year high of $49.47. The stock has a 50-day moving average of $40. and a 200-day moving average of $43.49. The company’s market cap is $4.684 billion.
Tenet Healthcare Corp. (NYSE:THC) last announced its earnings results on Tuesday, August 6th. The company reported ($0.49) earnings per share for the quarter, missing the analysts’ consensus estimate of $0.75 by $1.24. The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.46 billion. During the same quarter in the prior year, the company posted $0.10 earnings per share. The company’s quarterly revenue was up 6.9% on a year-over-year basis.
THC has been the subject of a number of recent research reports. Analysts at RBC Capital cut their price target on shares of Tenet Healthcare Corp. (NYSE:THC) from $52.00 to $47.00 in a research note to investors on Monday, August 12th. They now have a “sector perform” rating on the stock. Separately, analysts at Raymond James cut their price target on shares of Tenet Healthcare Corp. (NYSE:THC) from $52.00 to $50.00 in a research note to investors on Wednesday, August 7th. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Tenet Healthcare Corp. (NYSE:THC) in a research note to investors on Wednesday, August 7th. They now have a $45.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $47.11.
Tenet Healthcare Corporation (NYSE:THC), along with its subsidiaries, is an investor-owned health care services company whose subsidiaries and affiliates primarily operated 49 hospitals, 117 outpatient centers and Conifer Health Solutions (Conifer), which provides business process solutions to more than 600 hospital and other clients nationwide.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.